Reuters logo
BRIEF-BioInvent enters research collaboration, issues new shares to Pfizer
December 21, 2016 / 7:10 AM / 9 months ago

BRIEF-BioInvent enters research collaboration, issues new shares to Pfizer

Dec 21 (Reuters) - BioInvent

* Says announces cancer immunotherapy research collaboration and license agreement with Pfizer and issues new shares to Pfizer

* Says pfizer makes a $6 million equity investment in new shares in BioInvent

* Says under terms of deal, Pfizer will pay BioInvent approximately $10 million in early payments, including an upfront payment, early research funding, and a $6 million equity investment in new shares of BioInvent at a subscription price of SEK 2.56 per share

* Says assuming five antibodies are developed through to commercialization, BioInvent would be eligible for potential future payments related to certain development milestones, which could amount to more than $0.5 billion through the term of the deal, as well as up to double digit royalties related to any potential products that may result from the collaboration Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below